CXCL10 and microtia: Therefore, we hypothesize another potential mechanism of MA development in nAMD eyes under IVA treatment as follows: the antifibrotic immune reactions mediated by IP-10 become insufficient when intraocular VEGF is depleted following aflibercept treatment, and as a result, fibrosis and atrophy would progress under this altered condition.